Nuzenio

Iovance Biotherapeutics Stock

Iovance Biotherapeutics Stock news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 13 publisher sources 100/100 entity strength

Latest news

Iovance Biotherapeutics Stock Soars After the Company Posts Strong Q2 Earnings. Is It Heading Even Higher? - The Motley FoolThe Motley Fool · Mon, 10 Aug 2026 20:05:59 GMTIovance Biotherapeutics (IOVA) Stock Looks Fairly Valued Despite 222% Returns - simplywall.stsimplywall.st · Mon, 10 Aug 2026 17:39:21 GMTWhy Is Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Back in Market Conversation? - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 15:29:00 GMTDimensional Fund Advisors LP Purchases 1,106,592 Shares of Iovance Biotherapeutics, Inc. $IOVA - MarketBeatMarketBeat · Mon, 10 Aug 2026 07:48:28 GMTIs Iovance Biotherapeutics (IOVA) Undervalued On Q2 Earnings And Reaffirmed Guidance? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 11:32:06 GMTIovance Biotherapeutics (NASDAQ:IOVA) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeatMarketBeat · Sun, 09 Aug 2026 00:03:34 GMTIovance Biotherapeutics (IOVA) Stock Price Trails Record Revenue And Margin Gains - simplywall.stsimplywall.st · Sat, 08 Aug 2026 00:28:31 GMTIOVA Stock Slump Takes Wall Street, Retail By Surprise — Here’s Why - StocktwitsStocktwits · Fri, 07 Aug 2026 19:41:28 GMT

Timeline

Mon, 10 Aug 2026 20:05:59 GMTIovance Biotherapeutics Stock Soars After the Company Posts Strong Q2 Earnings. Is It Heading Even Higher? - The Motley Fool
Mon, 10 Aug 2026 17:39:21 GMTIovance Biotherapeutics (IOVA) Stock Looks Fairly Valued Despite 222% Returns - simplywall.st
Mon, 10 Aug 2026 15:29:00 GMTWhy Is Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Back in Market Conversation? - Kalkine Media
Mon, 10 Aug 2026 07:48:28 GMTDimensional Fund Advisors LP Purchases 1,106,592 Shares of Iovance Biotherapeutics, Inc. $IOVA - MarketBeat
Sun, 09 Aug 2026 11:32:06 GMTIs Iovance Biotherapeutics (IOVA) Undervalued On Q2 Earnings And Reaffirmed Guidance? - simplywall.st
Sun, 09 Aug 2026 00:03:34 GMTIovance Biotherapeutics (NASDAQ:IOVA) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Iovance Biotherapeutics Stock.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

13 distinct publisher/source names are currently connected to this entity page.